| 1. |
- Flossmann, Oliver, et al.
(författare)
-
Long-term patient survival in ANCA-associated vasculitis
- 2011
-
Ingår i: Annals of the Rheumatic Diseases. - : BMJ. - 1468-2060 .- 0003-4967. ; 70:3, s. 488-494
-
Tidskriftsartikel (refereegranskat)abstract
- Background Wegener's granulomatosis and microscopic polyangiitis are antineutrophil cytoplasm antibodies (ANCA)-associated vasculitides with significant morbidity and mortality. The long-term survival of patients with ANCA associated vasculitis treated with current regimens is uncertain. Objective To describe the long-term patient survival and possible prognostic factors at presentation in an international, multicentre, prospectively recruited representative patient cohort who were treated according to strictly defined protocols at presentation and included the full spectrum of ANCA-associated vasculitis disease. Methods Outcome data were collected for 535 patients who had been recruited at the time of diagnosis to four randomised controlled trials between 1995 and 2002. Trial eligibility was defined by disease severity and extent, covered the spectrum of severity of ANCA-associated vasculitis and used consistent diagnostic criteria. Demographic, clinical and laboratory parameters at trial entry were tested as potential prognostic factors in multivariable models. Results The median duration of follow-up was 5.2 years and 133 (25%) deaths were recorded. Compared with an age-and sex-matched general population there was a mortality ratio of 2.6 (95% CI 2.2 to 3.1). Main causes of death within the first year were infection (48%) and active vasculitis (19%). After the first year the major causes of death were cardiovascular disease (26%), malignancy (22%) and infection (20%). Multivariable analysis showed an estimated glomerular filtration rate <15 ml/min, advancing age, higher Birmingham Vasculitis Activity Score, lower haemoglobin and higher white cell count were significant negative prognostic factors for patient survival. Conclusion Patients with ANCA-associated vasculitis treated with conventional regimens are at increased risk of death compared with an age-and sex-matched population.
|
|
| 2. |
- Johnsen, Chris Andre, et al.
(författare)
-
Seasonal changes in muscle structure and flesh quality of 0+ and 1+ Atlantic salmon (Salmo salara L.):impact of feeding regime and possible roles of ghrelin
- 2013
-
Ingår i: Aquaculture Nutrition. - : Hindawi Limited. - 1353-5773 .- 1365-2095. ; 19:1, s. 15-34
-
Tidskriftsartikel (refereegranskat)abstract
- Growth performance, muscle cellularity, flesh quality, and plasma ghrelin were investigated in 0+ and 1+ farmed Atlantic salmon (Salmo salar L.) from 40 g to 4.3 kg. Reduced meal frequency was introduced in both smolt groups from ~1.5 kg; one meal per second day (<5 °C) to one daily meal (>5 °C), while control groups were fed one to three daily meals. Results show that 0+ salmon had higher final fibre number and density, pigment content, red colour intensity, firmer flesh, and lower fillet fat content than 1+ salmon at 4.3 kg, affected by season and smolt type. Muscle fibre recruitment was an important determinant of fillet firmness and colour, possibly influenced by the prenatal temperature regime. Fish fed reduced meal frequency showed temporal reduced feeding ration, but growth performance was not compromised in any smolt groups at harvest. However, fillet fat, gaping, and colour decreased by less frequent feeding, with permanent effects in 1+ salmon for gaping and fat. Reduced meal frequency is therefore considered to be a promising tool for managing important flesh quality attributes in salmon without compromising growth performance. It is also suggested that ghrelin stimulates short-term appetite, and perhaps also in the longer term.
|
|
